From Wikipedia, the free encyclopedia
Monoclonal antibody
Rafivirumab (CR57) is a
monoclonal antibody for the prophylaxis of
rabies.
[1]
[2]
[3]
References
-
^
"International Nonproprietary Names for Pharmaceutical Substances (INN)" (PDF). World Health Organization.
-
^ Kramer RA, Marissen WE, Goudsmit J, Visser TJ, Clijsters-Van der Horst M, Bakker AQ, et al. (July 2005).
"The human antibody repertoire specific for rabies virus glycoprotein as selected from immune libraries". European Journal of Immunology. 35 (7): 2131–45.
doi:
10.1002/eji.200526134.
PMID
15971273.
-
^ Franka R, Carson WC, Ellison JA, Taylor ST, Smith TG, Kuzmina NA, et al. (September 2017).
"In Vivo Efficacy of a Cocktail of Human Monoclonal Antibodies (CL184) Against Diverse North American Bat Rabies Virus Variants". Tropical Medicine and Infectious Disease. 2 (3): 48.
doi:
10.3390/tropicalmed2030048.
PMC
6082099.
PMID
30270905.